Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 11;17(2):236.
doi: 10.3390/ph17020236.

Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved?

Affiliations
Review

Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved?

Samuele Laudani et al. Pharmaceuticals (Basel). .

Abstract

Isoflavones are a group of (poly)phenols, also defined as phytoestrogens, with chemical structures comparable with estrogen, that exert weak estrogenic effects. These phytochemical compounds have been targeted for their proven antioxidant and protective effects. Recognizing the increasing prevalence of cardiovascular diseases (CVD), there is a growing interest in understanding the potential cardiovascular benefits associated with these phytochemical compounds. Gut microbiota may play a key role in mediating the effects of isoflavones on vascular and endothelial functions, as it is directly implicated in isoflavones metabolism. The findings from randomized clinical trials indicate that isoflavone supplementation may exert putative effects on vascular biomarkers among healthy individuals, but not among patients affected by cardiometabolic disorders. These results might be explained by the enzymatic transformation to which isoflavones are subjected by the gut microbiota, suggesting that a diverse composition of the microbiota may determine the diverse bioavailability of these compounds. Specifically, the conversion of isoflavones in equol-a microbiota-derived metabolite-seems to differ between individuals. Further studies are needed to clarify the intricate molecular mechanisms behind these contrasting results.

Keywords: equol; gut microbiota; isoflavones; phytoestrogens; polyphenols; vascular.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Gut-microbiota derived metabolites involved in cardiovascular disease. High protein intake leads to an increased production of TMA and p-cresol that negatively impacts gut permeability leading to systemic low-grade inflammation. IL-1beta (Interleukin-1 beta), ICAM (Intercellular Adhesion Molecule 1), NF-kB (Nuclear factor kappa B), TMA (Trimethylamine), TMAO (Trimethylamine N-Oxide), TNF-alpha (Tumor necrosis factor alpha), VCAM (Vascular cell adhesion protein). ↑ denotes increase.
Figure 2
Figure 2
Main equol mechanisms of action in equol-producers. Equol can increase eNOS activity resulting in higher levels of NO. This can react with superoxide producing peroxynitrite and increasing Nrf2 levels leading to upregulation of antioxidant genes. ARE (antioxidant response elements), CAT (Catalase), eNOS (Endothelial nitric oxide synthase), EC (Endothelial cell), ERK (Extracellular signal-regulated kinases), GPx (Glutathione peroxidase), HO-1 (Heme oxygenase 1), NO (Nitric oxide), PI3K (Phosphatidylinositol 3-kinase), NADPH (Nicotinamide adenine dinucleotide phosphate), SOD (Superoxide dismutase). ↑ denotes increase, ↓ denotes decrease.

Similar articles

References

    1. Incalza M.A., D’Oria R., Natalicchio A., Perrini S., Laviola L., Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul. Pharmacol. 2018;100:1–19. doi: 10.1016/j.vph.2017.05.005. - DOI - PubMed
    1. Wang L., Cheng C.K., Yi M., Lui K.O., Huang Y. Targeting endothelial dysfunction and inflammation. J. Mol. Cell. Cardiol. 2022;168:58–67. doi: 10.1016/j.yjmcc.2022.04.011. - DOI - PubMed
    1. Badimon L., Chagas P., Chiva-Blanch G. Diet and cardiovascular disease: Effects of foods and nutrients in classical and emerging cardiovascular risk factors. Curr. Med. Chem. 2019;26:3639–3651. doi: 10.2174/0929867324666170428103206. - DOI - PubMed
    1. Ding Q.-Y., Tian J.-X., Li M., Lian F.-M., Zhao L.-H., Wei X.-X., Han L., Zheng Y.-J., Gao Z.-Z., Yang H.-Y., et al. Interactions between therapeutics for metabolic disease, cardiovascular risk factors, and gut microbiota. Front. Cell. Infect. Microbiol. 2020;10:530160. doi: 10.3389/fcimb.2020.530160. - DOI - PMC - PubMed
    1. Angelino D., Godos J., Ghelfi F., Tieri M., Titta L., Lafranconi A., Marventano S., Alonzo E., Gambera A., Sciacca S., et al. Fruit and vegetable consumption and health outcomes: An umbrella review of observational studies. Int. J. Food Sci. Nutr. 2019;70:652–667. doi: 10.1080/09637486.2019.1571021. - DOI - PubMed

Grants and funding

J.G. was supported by the co-financing of the European Union—FSE-REACT-EU, PON Research and Innovation 2014–2020 DM1062/2021; CUP: E65F21002560001.

LinkOut - more resources